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We have cloned a Xenopus Dbf4-related factor named
Drf1 and characterized this protein by using Xenopus
egg extracts. Drf1 forms an active complex with the
kinase Cdc7. However, most of the Cdc7 in egg extracts
is not associated with Drf1, which raises the possibility
that some or all of the remaining Cdc7 is bound to an-
other Dbf4-related protein. Immunodepletion of Drf1
does not prevent DNA replication in egg extracts. Con-
sistent with this observation, Cdc45 can still associate
with chromatin in Drf1-depleted extracts, albeit at sig-
nificantly reduced levels. Nonetheless, Drf1 displays
highly regulated binding to replicating chromatin.
Treatment of egg extracts with aphidicolin results in a
substantial accumulation of Drf1 on chromatin. This ac-
cumulation is blocked by addition of caffeine and by
immunodepletion of either ATR or Claspin. These obser-
vations suggest that the increased binding of Drf1 to
aphidicolin-treated chromatin is an active process that
is mediated by a caffeine-sensitive checkpoint pathway
containing ATR and Claspin. Abrogation of this path-
way also leads to a large increase in the binding of Cdc45
to chromatin. This increase is substantially reduced in
the absence of Drf1, which suggests that regulation of
Drf1 might be involved in the suppression of Cdc45 load-
ing during replication arrest. We also provide evidence
that elimination of this checkpoint causes resumed ini-
tiation of DNA replication in both Xenopus tissue cul-
ture cells and egg extracts. Taken together, these obser-
vations argue that Drf1 is regulated by an intra-S-phase
checkpoint mechanism that down-regulates the loading
of Cdc45 onto chromatin containing DNA replication
blocks.
In eukaryotes, DNA replication is initiated by a multistep
process. Early in the G1-phase, replication initiation factors are
sequentially assembled onto replication origins to form pre-
replicative complexes (pre-RCs).1 At the core of the pre-RC is
the origin recognition complex, a six-subunit protein assembly
which is required for the subsequent loading of other pre-RC
components, including Cdc6/Cdc18, Cdt1, and the Mcms (1).
The second phase of the initiation process involves the transi-
tion of the pre-RC to a pre-initiation complex (2). A key deter-
minant for this step is the loading of Cdc45 onto pre-RCs (3, 4).
This binding requires the concerted actions of the Mcm10 and
Mus101 proteins, and the activities of two types of kinases: the
S-phase cyclin-dependent kinases (primarily cyclin E-Cdk2)
and Dbf4-Cdc7 (2, 3, 5–10). It has been proposed that the S-phase
cyclin-dependent kinases act as global activators of S-phase on-
set, whereas Dbf4-Cdc7 functions at the level of the individual
origins and is therefore required throughout S-phase (11, 12).
The Dbf4-Cdc7 kinase consists of a regulatory subunit, Dbf4,
and a catalytic subunit, Cdc7. In yeast, the Cdc7 subunit is
present at constant levels throughout the cell cycle, whereas
the Dbf4 subunit accumulates only during the G1/S-phase and
is then degraded by ubiquitin-mediated proteolysis (13–16).
The activation of Cdc7 by Dbf4 leads to the phosphorylation of
key substrates within the pre-RC. The best characterized sub-
strate both in vitro and in vivo is the Mcm2 subunit of the Mcm
complex (16–19). It has been suggested that phosphorylation of
Mcm2 alters the structure of the pre-initiation complex to
induce DNA unwinding (20). Mcm subcomplexes possess DNA
helicase activity in vitro and may be involved in DNA unwind-
ing during origin firing (21, 22).
In S-phase cells, the presence of stalled replication forks or
damaged DNA invokes a checkpoint response that delays entry
into mitosis until the defect has been repaired (23–25). These
regulatory mechanisms are known as S-M checkpoints. The
signal transduction cascades that underlie S-M checkpoints
have been well characterized in yeast model systems. A defect
is recognized by various sensor proteins, which elicit activation
of the effector kinases Chk1 or Cds1 (Rad53 in budding yeast),
depending on the nature of the checkpoint-inducing DNA sig-
nal. These kinases then phosphorylate key targets within the
cell cycle machinery to delay mitosis (24). In vertebrates, ho-
mologues of the Rad3 protein include ATR and ATM, both
members of the family of phosphatidylinositol 3-kinase-like
kinases (26). Evidence suggests that ATR is involved in the
detection of replication blocks, whereas ATM is activated in
response to DNA damage, leading to activation of Chk1 and
Chk2, respectively (27–32). Another protein that has been im-
plicated in the signaling in response to replication blocks is
Claspin, which was discovered in Xenopus as a Chk1-binding
protein that is essential for activation of Chk1 following induc-
tion of the replication checkpoint (33).
* This work was supported in part by a grant from the National
Institutes of Health (to W. G. D.). The costs of publication of this article
were defrayed in part by the payment of page charges. This article must
therefore be hereby marked “advertisement” in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted
to the GenBankTM/EBI Data Bank with accession number(s) AY328889
‡ Supported by a postdoctoral fellowship from the California Institute
of Technology. Current address: Dept. of Molecular Biology, Beckman
Research Institute, City of Hope, Duarte, CA 91010.
§ Supported by a National Institutes of Health training grant.
¶ Research associate of the Howard Hughes Medical Institute.
 To whom all correspondence should be addressed: Division of Biol-
ogy, 216-76, Howard Hughes Medical Institute, California Institute of
Technology, Pasadena, CA 91125. Tel.: 626-395-8433; Fax: 626-795-
7563; E-mail: dunphy@cco.caltech.edu.
1 The abbreviations used are: pre-RC, pre-replicative complex; XTC,
Xenopus tadpole cell; BrdUrd, bromodeoxyuridine; RACE, rapid ampli-
fication of cDNA ends; GST, glutathione S-transferase; Pipes, 1,4-
piperazinediethanesulfonic acid; CIB, chromatin isolation buffer; HBS,
HEPES-buffered saline.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 278, No. 42, Issue of October 17, pp. 41083–41092, 2003
© 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org 41083
Recent studies in vertebrate systems have also identified a
checkpoint pathway that prevents the onset of DNA replication
in the presence of damaged DNA. In Xenopus, one of the targets
of this checkpoint pathway is the Cdc45 protein. Reconstitution
of the DNA damage checkpoint in a Xenopus cell-free system
identified a pathway that activates ATM in response to DNA
containing double-strand breaks (7). ATM, in turn, down-reg-
ulates cyclin E-Cdk2 activity, thus preventing the loading of
Cdc45 onto chromatin and inhibiting DNA replication. Simi-
larly, Cdc45 is a target of a checkpoint induced by treatment
with etoposide, a topoisomerase II inhibitor (34). Activation of
this checkpoint, which is mediated by ATR, leads to the down-
regulation of Cdc7-associated kinase activity and inhibition of
the binding of Cdc45 to chromatin.
In yeast, similar pathways are involved in signaling a third
checkpoint, the intra-S-phase checkpoint. This checkpoint in-
hibits the firing of late replication origins in the presence of
stalled replication forks or DNA damage that occurs during
S-phase. In budding yeast, both subunits of the Dbf4-Cdc7
kinase undergo Rad53-dependent phosphorylation in response
to treatment with hydroxyurea. This phosphorylation releases
Dbf4-Cdc7 from chromatin, inhibits its kinase activity, and
thereby prevents the loading of Cdc45 (4, 13, 14, 35). In mam-
malian cells, a recent study showed that mice lacking Cdc7 are
embryonic lethal, demonstrating that this kinase is essential
for embryonic development (36). Furthermore, when Cdc7 was
conditionally removed from an embryonic stem cell line, cells
arrested within S-phase with partially replicated DNA. These
results support a critical role for the Dbf4-Cdc7 kinase in
ensuring the integrity of the DNA throughout the process of
replication.
In this study we have cloned a Xenopus member of the Dbf4
family, which we have named Xenopus Dbf4-related factor 1
(Drf1). The Drf1 protein is not essential for DNA replication or
the recruitment of Cdc45 to chromatin during normal S-phase.
However, Drf1 displays highly regulated binding to replicating
chromatin. Unlike the scenario in yeast and the etoposide-
induced pathway in Xenopus, we have observed that, following
replication fork arrest, Drf1 and Cdc7 accumulate on chroma-
tin. This binding is dependent upon ATR and Claspin, and is
abrogated by treatment with caffeine. The loss of Drf1 from
chromatin in the presence of caffeine correlates with an in-
crease in Cdc45 loading, which is also observed in aphidicolin-
treated extracts lacking ATR or Claspin. Caffeine is also capa-
ble of overriding an intra-S checkpoint that prevents further
initiation events in the presence of aphidicolin, both in XTC
cells and in egg extracts. We have established a biochemical
assay for this checkpoint by using alkaline agarose gels and
have observed a significant increase in the synthesis of small
DNA fragments when extracts are treated with aphidicolin and
caffeine. We hypothesize that activation of ATR by stalled
replication forks leads to the accumulation of Drf1 on chroma-
tin in a checkpoint-dependent manner. This checkpoint-de-
pendent association of Drf1 with chromatin may play a role in
preventing the binding of Cdc45 to chromatin during a repli-
cation arrest.
EXPERIMENTAL PROCEDURES
Cloning of a Xenopus Drf1 Homologue—The following oligonucleo-
tides were designed corresponding to sequences in a Xenopus expressed
sequence tag (accession no. BG408573) from the EMBL sequence li-
brary: sense, 5- gcagcaggacgatgaacccccattggcc-3; antisense, 5-ccttc-
cgttccgcagcctggatttgggac-3. A polymerase chain reaction (PCR) using a
Xenopus cDNA library generated with the Marathon RACE kit (Clon-
tech) served as the template. The 270-bp PCR product was subse-
quently biotinylated and used as a probe to screen a Xenopus oocyte
cDNA library in the pAX-NMT vector (37) using the ClonCapture cDNA
selection kit (Clontech). The same PCR fragment was radiolabeled and
used to isolate the full-length cDNA from the pool of clones enriched for
Drf1. Positive clones were verified by PCR, and sequencing of both
strands was performed with an ABI model 373 automated sequencer.
The GenBankTM accession no. for Drf1 is AY328889.
Antibodies—Xenopus Cdc7 was amplified by PCR with the following
oligonucleotides: 5-gggaattccatatgagttcgggcgataattcagg-3 and 5-act-
ggggaattcctaccgcatgtttttaaacagagc-3 (38). The RACE Xenopus cDNA
library described above served as the template. The full-length Cdc7
coding sequence was cloned into the NdeI and EcoRI sites of the pET3-
His6X vector, and the resulting plasmid was transformed into Codon
Plus Escherichia coli cells for expression and purification as described
(38). Antibodies were affinity-purified using standard methods with the
antigen described above conjugated to CNBr-activated Sepharose 4B
(Amersham Biosciences).
Antibodies were raised against an N-terminal fragment of Drf1. The
fragment was amplified by PCR using the following oligonucleotides:
sense, 5-gggaattccatatgcagcaggacgatgaacc-3; antisense, 5-gccaggt-
gaattcctatgtggggctcac-3. The 1270-bp fragment was cloned into the
NdeI and EcoRI sites of the pET3-His6X vector and expressed in Codon
Plus cells. The fusion protein was purified from inclusion bodies as
described above for Cdc7. Antibodies were affinity-purified as described
above. Affinity-purified antibodies against Xenopus Claspin, Chk1, and
ATR, and antisera against Orc2 were described previously (33, 39, 40).
Antisera against Xenopus Cdc45 were generously provided by J. Lee.
Monoclonal antibodies against human Mcm2 were obtained commer-
cially (BM28, BD Biosciences). Antibodies recognizing Xenopus Mcm4
were kindly provided by J. Blow. Control rabbit IgG was obtained from
Zymed Laboratories Inc..
Xenopus GST-Mcm2 was cloned into pGEX4T2 vector (Amersham
Biosciences), expressed in Codon Plus cells, and purified with GST-
agarose. Recombinant geminin was purified as described (33, 39, 40).
Egg Extracts—Xenopus egg extracts were prepared as described (41).
Egg extracts arrested in interphase because of the presence of unrep-
licated DNA routinely contained 3000 demembranated Xenopus sperm
nuclei/l of extract and 100 g/ml aphidicolin. Caffeine was added to a
final concentration of 5 mM from a 100 mM solution freshly dissolved in
10 mM Pipes-KOH (pH 7.5).
Immunodepletion—Immunodepletions of Chk1 and Claspin from egg
extracts were carried out with Affiprep-protein A beads (Bio-Rad) as
described previously (33). For immunodepletion of Cdc7 and Drf1, 100
l of serum coupled to Affiprep-protein A beads was used per 100 l of
CSF-arrested extract, during two rounds of depletion. Pre-immune
serum served as a control. For immunodepletion of ATR, 25 g of
antibody coated on protein A-magnetic beads (Dynal) was incubated
with extracts on ice for 1 h. The beads were removed with a magnet, and
the procedure was repeated.
Chromatin Isolation—Egg extracts (100 l) containing 3000 sperm
nuclei/l were overlaid on a 1-ml sucrose cushion containing chromatin
isolation buffer (CIB; 20 mM HEPES-KOH (pH 7.6), 1 M sucrose, 80 mM
KCl, 25 mM potassium gluconate, and 10 mM magnesium gluconate),
and centrifuged at 6100  g for 5 min. The pellets were washed twice
with CIB  0.5% Nonidet P-40, and centrifuged as above. The chroma-
tin pellets were boiled in 2 SDS sample buffer and subjected to
SDS-PAGE. To elute chromatin-associated proteins, chromatin pellets
were prepared from 400 l of extract by overlaying 200 l on a 1-ml
sucrose cushion in duplicate. Samples were centrifuged at 6100  g for
5 min. Chromatin pellets were washed twice with CIB and then once
with CIB  0.5% Nonidet P-40. The supernatants were removed, and
the chromatin pellets were resuspended in 100 l of 1 M NaCl, 10 mM
HEPES-KOH (pH 7.6). Samples were incubated on ice for 10 min and
then centrifuged at 11,700 g for 5 min. The supernatant contained the
proteins eluted from chromatin.
Replication Assays—To monitor DNA replication, egg extracts were
incubated with sperm nuclei (1000–3000 sperm nuclei/l), 0.4 mM
CaCl2, 100 g/ml cycloheximide, and 1 l of [-
32P]dATP for 90 min at
room temperature. The reaction was terminated upon addition of an
equal volume of 2 replication stop buffer (80 mM Tris-HCl (pH 8), 8 mM
EDTA, 0.13% phosphoric acid, 10% Ficoll, 5% SDS, and 0.2% bromphe-
nol blue), and 1 mg/ml proteinase K, followed by incubation at 55 °C for
1 h. Samples were run on 1% agarose gels, dried, and detected by a
PhosphorImager (Amersham Biosciences).
Immunoprecipitations and Kinase Assays—For immunoprecipitation
of Drf1 and Cdc7 from egg extracts, 100 l of extract was diluted 3-fold
with 10 mM HEPES-KOH (pH 7.6), 150 mM NaCl, 2.5 mM EGTA, 20 mM
-glycerophosphate, and 0.5% Nonidet P-40, and centrifuged at
11,700  g for 10 min to pellet nuclei. Supernatants were removed and
incubated with 5 g of affinity-purified antibody bound to Affiprep-
protein A beads for 1 h at 4 °C with rotation. The beads were washed
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FIG. 1. Sequence analysis of Xenopus Drf1. A, phylogenetic tree displaying the evolutionary relationships among the following Dbf4-like
family members: Xenopus (XDrf1 and XDbf4), Saccharomyces cerevisiae (ScDbf4), human (HsDrf1 and HsASK), Schizosaccharomyces pombe
(SpHsk1), mouse (MuDbf4), Chinese hamster (ChDbf4), Drosophila (Chiffon), and Aspergillus (nimO). B, schematic of the Xenopus Drf1 protein
illustrating the three motifs conserved in Dbf4-related proteins. Numbers correspond to amino acid position in the sequence of Drf1. C, alignment
of the motifs in B with those in other species. Numbers in parentheses correspond to amino acid positions in each respective protein.
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three times with buffer X (10 mM HEPES-KOH (pH 7.6), 80 mM NaCl,
2.5 mM EGTA, 20 mM -glycerolphosphate, and 0.1% Nonidet P-40),
then once with HBS (150 mM NaCl, 10 mM HEPES-KOH (pH 7.6)). For
immunoprecipitation of proteins eluted from chromatin, the superna-
tant was removed and diluted 8-fold with 50 mM NaCl, 10 mM HEPES-
KOH (pH 7.6) and incubated with 5 g of antibody bound to Affiprep-
protein A beads for 1 h at 4 °C with rotation. The beads were washed
three times with buffer X, and then once with HBS. For in vitro kinase
assays, the beads were resuspended in HBS. One half was boiled in 2
SDS sample buffer, subjected to SDS-PAGE, and immunoblotted for
Drf1 and Cdc7. The other half was incubated with kinase buffer (50 mM
Tris-HCl (pH 7.5), 10 mM MgCl2, 1 mM dithiothreitol, and 50 M ATP)
containing [-32P]ATP and 1 g of GST-Mcm2. Samples were incu-
bated at room temperature for 15 min with rotation, then boiled in 2
SDS sample buffer, subjected to SDS-PAGE, and detected by a
PhosphorImager.
Cell Culture and Immunofluorescence—XTC-2 cells were grown on
poly-D-lysine-coated coverslips in 61% Leibovitz’s (L-15) medium sup-
plemented with 10% fetal calf serum and antibiotics. Caffeine-treated
cells were incubated with 5 mM caffeine 90 min prior to aphidicolin
treatment, where applicable. The cells were then incubated with 100 M
BrdUrd and 5 g/ml aphidicolin where indicated. At 5.5 h, cells were
fixed with 3% paraformaldehyde, permeabilized with 0.1% Triton
X-100, and subjected to indirect immunofluorescence. For BrdUrd vi-
sualization, cells were re-fixed with 0.1% formaldehyde and incubated
for 10 min in 2 M HCl and 0.1% Triton X-100 at room temperature. The
acid was washed away, and the immunofluorescence procedure was
repeated with anti-BrdUrd (Roche) as the primary antibody and Texas
Red conjugated anti-mouse IgG (Jackson Laboratories) at a 1:500 dilu-
tion as the secondary antibody. The coverslips were washed (with 1
g/ml Hoechst 33258 in the last wash) and mounted onto glass slides
with Vectamount (Vector Laboratories). The samples were imaged with
a SpotRT CCD camera (Diagnostic Instruments) and analyzed with
Adobe Photoshop.
Alkaline Gel Electrophoresis—Replication reactions (typically 40 l
of egg extract) were resuspended in 300 l of StopN (20 mM Tris-HCl
(pH 8), 200 mM NaCl, 5 mM EDTA, and 0.5% SDS) containing 2 g/ml
RNase, and digested for 10 min at 37 °C. Proteinase K (200 g/ml) was
added, and samples were incubated for another 30 min at 37 °C. DNA
was extracted twice with phenol:chloroform:isoamyl alcohol (Sigma)
and then precipitated with ethanol. Pellets were resuspended in 10 l
of 10 mM EDTA, and then diluted with an equal volume of 2 alkaline
loading buffer (100 mM NaOH, 2 mM EDTA, 2.5% Ficoll, and 0.025%
bromcresol green). Samples were loaded onto gels containing 1% agar-
ose in 50 mM NaCl and 1 mM EDTA, and run overnight in alkaline gel
running buffer (50 mM NaOH, 1 mM EDTA). Gels were fixed with 7%
trichloroacetic acid, dried, and autoradiographed.
RESULTS
Identification of a cDNA Encoding Xenopus Drf1—A Xeno-
pus homologue from the Dbf4 family was cloned by first ampli-
fying a 270-bp sequence with oligonucleotides designed to rec-
ognize a Xenopus expressed sequence tag with homology to
Dbf4 proteins in other species. This fragment was then used to
screen a Xenopus cDNA library to isolate the full-length open
reading frame. Recently, a Xenopus Dbf4 sequence has been
entered in the GenBankTM data base (accession no. AB095983).
Our cloned protein shares significant sequence homology with
this protein (28% identical) but represents a second, distinct
Dbf4-like polypeptide (Fig. 1A). In humans, two Dbf4-like pro-
teins have been identified, both of which activate Cdc7 (19, 42).
The cDNA that we have identified in Xenopus encodes a 772-
amino acid protein that is homologous to both human proteins
(32 and 26% identical to human Drf1 and ASK, respectively)
but shares a higher identity with Drf1 (Fig. 1A). In comparison
with other vertebrate Dbf4 proteins, Xdrf1 shares 29% identity
with the hamster Dbf4 and 30% identity with the mouse Dbf4.
Based on the sequence and the experimental evidence pre-
sented below, we believe that we have cloned a Dbf4-related
factor, and have named this protein Xdrf1 (referred to hereaf-
ter as Drf1).
Three distinct amino acid motifs have been described for the
Dbf4 gene family: motifs N, M, and C (43). Motif N shares
similarity to a BRCT-like domain and may be functionally
important for the replication and DNA damage checkpoints;
mutations in this region of the fission yeast homologue, Dfp1/
Him1, do not affect the replication functions of the kinase but
cause hypersensitivity to drugs that block DNA replication or
damage DNA (44). Motif M consists of a proline-rich region,
and motif C resembles a CCHH-type zinc finger motif (43).
These two regions of Dfp1/Him1 are both necessary and suffi-
cient for full activation of the kinase (44). All three of these
motifs are highly conserved in the Xenopus Drf1 protein (Fig. 1,
B and C).
Drf1 Is Dispensable for DNA Replication and Cdc45 Load-
ing—We raised antibodies against an N-terminal fragment of
the Xenopus Drf1 protein. This antibody efficiently detects the
endogenous Drf1 protein by immunoblotting (Fig. 2A). Al-
though the predicted molecular mass of Drf1 is 85 kDa, we
found that the protein detected by two different antibodies
raised against Drf1 migrated more slowly, at 150 kDa. Upon
removal of Drf1 with anti-Drf1 antibodies, we observed that a
FIG. 2. Drf1 forms an active kinase with Cdc7 but is not essen-
tial for DNA replication. A, Western blot analysis of Drf1 and Cdc7
in untreated, Drf1-depleted, and mock-depleted extracts. B, sperm nu-
clei were incubated in interphase extracts from A in the presence of
[-32P]dATP for 90 min. DNA replication was determined as described
under “Experimental Procedures.” C, sperm nuclei were incubated for
60 min in mock-depleted and Drf1-depleted extracts. Chromatin frac-
tions were isolated and immunoblotted with antibodies against Drf1,
Cdc45, Claspin, Mcm2, and Orc2. D, sperm nuclei were incubated in
interphase extracts for 100 min in the absence or presence of 30 M
etoposide. Chromatin fractions were isolated and immunoblotted with
antibodies against Drf1, Cdc7, Cdc45, and Orc2. E, immunoprecipita-
tion of Cdc7 and Drf1 from interphase extracts. Half of the immuno-
precipitate was immunoblotted with antibodies against Drf1 and Cdc7.
The other half was incubated with GST-Mcm2 and [-32P]ATP for
in vitro kinase assays.
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significant amount of Cdc7 remained in the Drf1-depleted ex-
tract. Possible explanations are that there is a pool of free Cdc7
or that a second Dbf4-like protein may also form a complex
with Cdc7, as is the case in human cells. To determine whether
Drf1 is required for DNA synthesis, we depleted Drf1 from egg
extracts and monitored the extent of DNA replication. We
observed no defect in DNA replication in the absence of Drf1
compared with the mock-depleted or untreated extracts (Fig.
2B). This result contrasts with the nearly complete inhibition of
replication that has been reported for depletion of the Xenopus
Cdc7 protein (9, 38). It is possible that our antibodies failed to
completely deplete Drf1 from the extracts, thereby allowing
some residual kinase to promote DNA replication. However,
immunoprecipitation of Drf1 from a Drf1-depleted extract
failed to detect any Drf1 protein (data not shown). Hence, our
results suggest that either Drf1 is not the regulatory subunit of
Cdc7 that is essential for DNA replication or, alternatively,
that when Drf1 is depleted from extracts, the replication func-
tion of the kinase is performed by a Dbf4-Cdc7 complex.
In yeast, both the Dbf4 and Cdc7 subunits are required for
the loading of Cdc45 onto chromatin. In Xenopus, a similar
requirement has been shown for Cdc7 (45). To determine
whether depletion of Drf1 affects the ability of Cdc45 to bind to
chromatin, we analyzed the chromatin fraction of Drf1-de-
pleted extracts that had been incubated with sperm nuclei for
60 min (Fig. 2C). Although we observed a significant reduction
in the levels of chromatin-bound Cdc45 in the Drf1-depleted
extracts compared with the control extract, Cdc45 was none-
theless still capable of binding to chromatin. Consistent with
this observation, Claspin, which is dependent on Cdc45 for its
recruitment to chromatin during interphase (39), was also
bound to chromatin in the absence of Drf1, albeit at lower
levels. As expected, the binding of components of the pre-RC,
including Orc2 and Mcm2, was not dependent on Drf1. These
results are consistent with the hypothesis that another mem-
ber of the Dbf4 family must contribute to the replication func-
tion of the Cdc7 kinase.
A recent report identified a Xenopus Dbf4 protein as the
target of an etoposide-induced checkpoint (34). In the presence
of etoposide, it was observed that Dbf4 failed to bind to chro-
matin, resulting in the loss of Cdc45 loading. We tested
whether we could also detect the loss of chromatin binding of
Drf1 in the presence of etoposide (Fig. 2D). Although etoposide
efficiently inhibited DNA replication (data not shown), we
failed to observe any change in the chromatin binding of Drf1.
However, the chromatin binding of Cdc45 was inhibited by
etoposide, consistent with the published results. Collectively,
these results support the conclusion that Drf1 constitutes a
second member of the Dbf4 family in Xenopus laevis.
Given the different properties of Xenopus Dbf4 and Drf1, we
verified that Drf1 is indeed a regulatory subunit of the Cdc7
kinase. Using Drf1 and Cdc7 antibodies, we tested whether
these proteins could be co-immunoprecipitated with each other
from Xenopus egg extracts (Fig. 2E, upper panel). We found
that Drf1 and Cdc7 formed a stable complex that could be
immunoprecipitated with antibodies against either subunit.
This complex also formed an active kinase that readily phos-
phorylated GST-Mcm2 in vitro (Fig. 2E, bottom panel). These
results confirm that the Drf1-Cdc7 complex has kinase activity.
Drf1 Binds to Chromatin in a Regulated Manner—We next
characterized the binding of Drf1 to chromatin. As was re-
ported for Cdc7 (9), Drf1 binds to chromatin after Mcm2 and
around the same time as Cdc45 (Fig. 3A). Because both Drf1
and Cdc7 bind to chromatin at the onset of S-phase, we tested
whether each subunit requires the other to bind to chromatin
(Fig. 3B). In Drf1-depleted extracts, Cdc7 binding was barely
detectable. Likewise, in Cdc7-depleted extracts, we failed to
observe any chromatin-bound Drf1. These observations suggest
that Drf1 and Cdc7 bind to chromatin as a complex or indirectly
stabilize each other on chromatin. Furthermore, when extracts
were treated with geminin, an inhibitor of Cdt1-dependent
Mcm loading (46), the binding of both Drf1 and Cdc7 to chro-
matin was strongly inhibited (Fig. 3C). This finding indicates
that binding of Drf1 and Cdc7 is dependent upon the pre-RC.
Chromatin Binding of Drf1 and Cdc7 following Aphidicolin
Treatment Is Checkpoint-regulated—Because Cdc7 and Dbf4
are regulated by the DNA replication checkpoint in Xenopus
and in yeast, we tested whether Drf1 may also have a check-
point-specific function. In the presence of aphidicolin, which
induces a block to replication, it has been reported that the
binding of Cdc7 to chromatin is increased (45). We observed a
similar increase in the levels of Drf1 following incubation of
sperm nuclei in extracts in which the replication checkpoint
was activated by aphidicolin (Fig. 4A). This increase is also
sensitive to geminin, which is consistent with a requirement for
initiation to occur to establish the replication checkpoint in-
duced by aphidicolin (Fig. 3C). However, the increase in Drf1
and Cdc7 binding to chromatin could simply be a consequence
of the increased number of replication forks that stall in re-
sponse to aphidicolin. In this case, we would predict that the
FIG. 3. Drf1 is a chromatin-binding protein. A, whole egg extract and chromatin fractions isolated at various times (minutes) following
addition of sperm chromatin to interphase extracts were immunoblotted with antibodies against Drf1, Cdc7, Cdc45, Mcm2, and Orc2. The second
lane depicts a mock chromatin fraction from an extract lacking DNA. B, mock-depleted, Drf1-depleted, and Cdc7-depleted extracts were incubated
with sperm nuclei for 100 min. Subsequently, chromatin fractions were immunoblotted with antibodies against Drf1, Cdc7, and Mcm2. C, sperm
nuclei were incubated in egg extracts in the absence and presence of aphidicolin (Aph) and geminin, as indicated. After 100 min, chromatin
fractions were immunoblotted with antibodies against Drf1, Cdc7, Mcm4, and Orc2.
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chromatin binding of Drf1 and Cdc7 would be independent of
the checkpoint signaling pathways. To test this possibility, we
treated extracts with aphidicolin and caffeine, an inhibitor of
ATM and ATR, to determine whether inhibition of checkpoint
signaling affects the levels of Drf1 and Cdc7 on chromatin. We
found that the levels of both Drf1 and Cdc7 on chromatin were
significantly reduced in the presence of caffeine (Fig. 4A). This
behavior is in stark contrast to the regulation of Cdc45. A slight
increase in chromatin binding of Cdc45 was observed in the
presence of aphidicolin, but the association of Cdc45 with chro-
matin was dramatically up-regulated upon addition of caffeine
(Fig. 4A). This observation suggests that Cdc45 loading may be
suppressed by a checkpoint pathway that is activated by a
replication block.
To characterize further the checkpoint-dependent chromatin
binding of Drf1 and Cdc7, we tested whether this binding
requires specific components of the checkpoint-signaling path-
way. For this purpose, we depleted ATR, Claspin, or Chk1 from
egg extracts (Fig. 4B). Sperm nuclei and aphidicolin were
added to these depleted extracts, and chromatin fractions were
immunoblotted for Drf1 and Cdc7. In both the ATR-depleted
and Claspin-depleted extracts, we found that Drf1 and Cdc7
levels were reduced as compared with the mock-depleted con-
trols and were very similar to the levels observed in extracts
treated with both aphidicolin and caffeine (Fig. 4C). In con-
trast, when Chk1 was depleted, there was no effect on the
chromatin binding of either Drf1 or Cdc7. These results suggest
that upstream components of the replication checkpoint path-
way are required for the recruitment or stability of Drf1 and
Cdc7 on chromatin following aphidicolin treatment, yet the
chromatin binding of Drf1 and Cdc7 is not dependent on the
effector kinase Chk1. Another significant finding involves
the effect of ATR and Claspin depletion on Cdc45. When ex-
tracts were treated with aphidicolin in the absence of ATR or
Claspin, Cdc45 levels on chromatin increased significantly,
similar to those observed in the presence of both aphidicolin
and caffeine (Fig. 4, A and C). In contrast, depletion of Chk1
had no effect on Cdc45. From these results we conclude that the
regulated chromatin binding of Drf1, Cdc7, and Cdc45 during a
replication block is dependent upon ATR and Claspin.
These findings suggest that a replication checkpoint path-
way may respond to stalled replication forks by suppressing
further loading of Cdc45 at these forks or at other origins. To
test whether Drf1 plays a role in preventing additional Cdc45
FIG. 4. Regulation of the binding of Drf1 and Cdc7 to chromatin. A, sperm nuclei were incubated for 100 min in interphase extracts with
no drug, aphidicolin (Aph), or aphidicolin plus caffeine. Chromatin fractions were immunoblotted for Drf1, Cdc7, Cdc45, Mcm2, and Orc2. B,
untreated, mock-depleted, ATR-depleted, Claspin-depleted, and Chk1-depleted extracts were immunoblotted with anti-ATR, anti-Claspin, and
anti-Chk1 antibodies. C, the extracts described in B were incubated with sperm nuclei in the presence of no drug, aphidicolin, or aphidicolin plus
caffeine for 100 min. Chromatin was isolated and immunoblotted with antibodies against Xenopus Drf1, Cdc7, and Cdc45. D, interphase,
Drf1-depleted, and mock-depleted extracts were incubated with sperm nuclei and either no drug, aphidicolin, or aphidicolin plus caffeine for 100
min. Chromatin fractions were immunoblotted with antibodies against Drf1, Cdc7, Cdc45, and Orc2.
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from binding to chromatin, we depleted Drf1 from egg extracts
and then examined the levels of chromatin-bound Cdc45 in
these extracts in the presence of no drug, aphidicolin, or aphidi-
colin and caffeine (Fig. 4D). In mock-depleted extract, low
levels of Cdc45 were detected in the absence and presence of
aphidicolin, whereas a significant increase in Cdc45 loading
was observed in the presence of both aphidicolin and caffeine.
However, only a small increase in the binding of Cdc45 oc-
curred in Drf1-depleted extracts that were treated with both
aphidicolin and caffeine. These findings imply that Drf1 is
involved in regulating Cdc45 loading during a replication block.
Regulation of Drf1-Cdc7 Kinase Activity during the Replica-
tion Block—In Xenopus egg extracts, treatment with the DNA
damaging agent etoposide disrupts the interaction between
Dbf4 and Cdc7. This treatment therefore inactivates the ki-
nase and prevents the binding of Cdc45 to chromatin (34). To
determine whether Drf1 and Cdc7 are regulated in a similar
fashion in response to aphidicolin, we tested whether both
subunits could be co-immunoprecipitated with each other in
the extract and on chromatin. In both fractions, Drf1 and
Cdc7 co-immunoprecipitated with each other in the presence
of aphidicolin (Fig. 5, A and B). This observation suggests
that the Drf1-Cdc7 complex is maintained during a replica-
tion block.
We next measured the kinase activity associated with Drf1
that had been immunoprecipitated from either the extract or
chromatin fractions, using GST-Mcm2 as a substrate. In the
extract, no obvious change in the kinase activity was observed
in response to aphidicolin or aphidicolin plus caffeine (Fig. 5C).
Similar results were observed when the kinase activity of the
chromatin-eluted Drf1-Cdc7 complex was measured (data not
shown). Taken together, these results indicate that the aphidi-
colin-induced checkpoint does not lead to a readily discernible
inhibition of the kinase activity of Drf1-Cdc7 under these assay
conditions.
A Caffeine-sensitive Checkpoint Inhibits Replication in XTC
Cells during Aphidicolin Arrest—Our chromatin binding data
suggest that an aphidicolin-induced, caffeine-sensitive check-
point regulates the binding of Drf1 and Cdc7 to chromatin. The
aphidicolin-dependent increase in the chromatin binding cor-
relates with a suppression of Cdc45 that is reversed upon
abrogation of the checkpoint with caffeine. These observations
suggest that Drf1 is a target of an intra-S checkpoint that
regulates the loading of Cdc45. To investigate whether an
intra-S checkpoint exists in Xenopus cells, we treated Xenopus
tadpole cells (XTC cells) with BrdUrd and monitored its incor-
poration in asynchronous cells after a 5.5-h incubation with
aphidicolin or with aphidicolin and caffeine. Treatment with
caffeine alone or Me2SO served as controls. We then counted
the percentage of the total number of cells that exhibited punc-
tate BrdUrd staining, an indicator that these cells were in
S-phase. As expected, we observed a dramatic decrease in the
number of BrdUrd-positive S-phase cells after treatment with
aphidicolin (Fig. 6, A and B). When caffeine was added together
with aphidicolin, the percentage of cells increased significantly
(p  0.01), approximately to levels observed in untreated cells
or cells treated with caffeine alone. Similar results were re-
corded when we calculated the percentage of punctate BrdUrd
cells over the total number of BrdUrd-positive cells (data not
shown). However, the intensity of the BrdUrd labeling in the
nuclei of cells treated with both caffeine and aphidicolin was
strongly reduced compared with untreated S-phase cells (Fig.
6A, compare left and right panels). These observations indicate
that caffeine mostly does not reverse the inhibitory effect of
aphidicolin on DNA polymerase activity to allow extensive
elongation and completion of DNA synthesis. Instead, the en-
hanced incorporation of BrdUrd in the presence of caffeine may
reflect the abrogation of a checkpoint that suppresses origin
unwinding and early events associated with the initiation of
DNA replication.
Caffeine-sensitive Inhibition of Nascent Strand DNA Synthe-
sis in Xenopus Extracts—We next sought a biochemical assay
to determine whether an analogous intra-S checkpoint may
operate in Xenopus egg extracts. It has been reported that in
the presence of lower doses of aphidicolin (10 g/ml), small
DNA fragments ranging in size from 0.1 to 1 kb accumulate
during a replication block. These fragments can be detected in
alkaline agarose gels (47). Using this dose of aphidicolin, we
were able to detect a low level of DNA fragments that accumu-
lated within this same size range (Fig. 7A). We hypothesized
that, if a checkpoint functions to suppress origin firing in the
presence of aphidicolin, perhaps this checkpoint may be re-
versed by caffeine, thereby allowing more synthesis of these
small DNA fragments. Indeed, in extracts treated with both
aphidicolin and caffeine, we observed a significant increase in
the accumulation of these small fragments compared with
treatment with aphidicolin alone (Fig. 7A). Although some of
the fragments appeared longer than in the aphidicolin-blocked
sample, the bulk of DNA synthesized in the presence of caffeine
remained within the same size range. This observation sug-
gests that aphidicolin still prevents elongation in the presence
of caffeine, but some aspect of initiation is under checkpoint
control.
DISCUSSION
In this work, we have cloned and characterized Xenopus
Drf1, a member of the Dbf4 family of proteins. Based on pub-
lished results that describe another Dbf4-related homologue in
Xenopus (34) and its reported sequence, Drf1 represents a
second, distinct protein. Thus, Xenopus is the second vertebrate
species, after humans, to have two Dbf4 homologues. In fission
yeast, two Dbf4-like complexes have also been identified: Dfp1-
Hsk1 and Spo6-Spo4. Both complexes form active kinases, but
their functions are quite divergent. Dfp1-Hsk1, which is most
analogous to mammalian Dbf4-Cdc7, is essential for DNA rep-
FIG. 5. The kinase activity of Drf1-Cdc7 is not affected by
aphidicolin treatment. Interphase extracts were incubated without
aphidicolin, with aphidicolin, and with aphidicolin plus caffeine. The
extracts (A) and chromatin fractions isolated from these extracts (B)
were immunoprecipitated (IP) with control, anti-Cdc7, and anti-Drf1
antibodies. The immunoprecipitates were then probed for Cdc7 and
Drf1 by immunoblotting. C, the kinase activity of immunoprecipitates
from A was tested in vitro using GST-Mcm2 as a substrate.
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lication (15, 48, 49), whereas Spo6-Spo4 is involved in progres-
sion through the second meiotic division (50). In humans, the
two Dbf4-like proteins (ASK and Drf1) regulate the same cat-
alytic partner, Cdc7. Both complexes are activated during S-
phase. Although ASK-Cdc7 is essential for DNA replication
(19, 51), it is not known what role human Drf1-Cdc7 plays
during this phase of the cell cycle.
We have found that the Xenopus Drf1 homologue is dispen-
sable for DNA replication and loading of Cdc45 onto chromatin.
It is possible that both Drf1-Cdc7 and Dbf4-Cdc7 complexes
contribute to Cdc45 loading, and therefore a defect in replica-
tion would be observed only by depleting both regulatory sub-
units. This possibility would be consistent with our findings
that Cdc45 levels on chromatin are reduced in Drf1-depleted
extracts, and published results that depletion of the Cdc7 sub-
unit is sufficient to block DNA replication and Cdc45 loading
(9, 38). Although Drf1 may not be essential for DNA replication
in Xenopus, it does bind to chromatin in a highly regulated
manner. In particular, it associates with chromatin at S-phase
onset at around the same time as Cdc7 and Cdc45. The binding
of Drf1 to chromatin is sensitive to geminin, as was shown
previously for Cdc7 (45), implying that binding of Drf1 and
Cdc7 occurs once the Mcm complex has been recruited to the
pre-RC. Although the exact function of chromatin-bound Drf1
and Cdc7 is not known, the two subunits form a complex on
chromatin that exhibits kinase activity toward Mcm2 in vitro.
Upon further characterization of Drf1, we found that the
chromatin binding properties of this protein are regulated dur-
ing a replication block. Whereas treatment with hydroxyurea
causes the budding yeast Dbf4-Cdc7 complex to dissociate from
chromatin (13), a replication block induced by aphidicolin re-
sults in the accumulation of both Xenopus Drf1 and Cdc7 on
chromatin. This binding is sensitive to caffeine and diminished
in extracts lacking ATR or Claspin. These observations argue
against the model that Drf1 and Cdc7 remain on chromatin
simply because of the presence of stalled replication forks.
Instead, these results suggest that Drf1 and Cdc7 are either
actively recruited to or stabilized on chromatin by signaling
components of the caffeine-sensitive replication checkpoint.
Importantly, we found that depletion of Drf1 substantially
reduced the effect of caffeine on Cdc45 loading, suggesting that,
although Cdc45 can bind to chromatin in a Drf1-depleted ex-
FIG. 6. Caffeine induces some BrdUrd (BrdU) incorporation in aphidicolin (Aph)-treated XTC cells. A, immunofluorescence of
BrdUrd-labeled XTC cells treated with Me2SO, aphidicolin alone, or aphidicolin and caffeine for 5.5 h. BrdUrd incorporation was visualized using
an anti-BrdUrd antibody (upper panels), and Hoechst dye was used for nuclear DNA staining (lower panels). B, quantification of cells in A
expressed as the percentage of cells with punctate BrdUrd staining over the total number of cells.
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tract to allow normal replication to proceed, the suppression of
Cdc45 by checkpoint activation involves Drf1. One possible
model is that the Drf1-Cdc7 kinase on chromatin phosphoryl-
ates different targets under checkpoint conditions than during
DNA replication, resulting in the inhibition of further Cdc45
loading. Alternatively, Drf1 and Cdc7 may simply be seques-
tered on chromatin in a manner that contributes to the lack of
Cdc45 loading at sites of initiation. This concept is consistent
with the model proposed by Edwards et al., in which Cdc7 can
interact with Mcms throughout broad regions of chromatin
outside of the initiation sites (52).
The activation of a caffeine-sensitive replication checkpoint
that targets the chromatin binding of Cdc45 shares certain
similarities with the DNA damage pathways previously re-
ported in Xenopus cell-free extracts. Treatment with etoposide,
an inhibitor of topoisomerase II, results in activation of ATR,
which leads to disruption of the Dbf4-Cdc7 complex and inhi-
bition of its kinase activity. This inhibition prevents the load-
ing of Cdc45 and entry into S-phase (34). Interestingly, Dbf4
dissociates from chromatin under these conditions, but Cdc7
remains bound. In contrast, Drf1 remains associated with chro-
matin in the presence of etoposide, suggesting that its regula-
tion in response to DNA damage differs from that of Dbf4.
In the presence of aphidicolin, limited origin firing and elon-
gation can occur before replication forks stall (10, 47). These
arrested replication structures are known to activate a check-
point pathway that activates ATR, Claspin, and Chk1 to inhibit
entry into mitosis (28–31, 33). However, results from yeast and
mammalian systems have also identified an intra-S checkpoint
pathway that functions to prevent the initiation of replication
at late origins in the presence of stalled replication forks (53–
55). This pathway is also caffeine-sensitive and involves sev-
eral components of the S-M checkpoint, suggesting that acti-
vation of the replication checkpoint has multiple cell cycle
targets. Our data from XTC cells identified a similar caffeine-
sensitive intra-S checkpoint that is activated by aphidicolin.
Only very low levels of BrdUrd labeling could be detected when
cells were treated with aphidicolin, but distinctly punctate
BrdUrd labeling was observed when caffeine was also added. It
is important to note that the overall intensity of the BrdUrd
labeling was not nearly as high as in the untreated nuclei,
consistent with continued inhibition of DNA polymerases. Nev-
ertheless, these results suggest that some aspect of DNA un-
winding is inhibited by the replication checkpoint pathway in
the presence of incompletely replicated DNA.
Using alkaline agarose gels, we have established a biochem-
ical assay for the checkpoint-dependent block to replication in
response to aphidicolin in egg extracts. Consistent with our
observations in XTC cells, treatment with aphidicolin and caf-
feine allowed the synthesis of short nascent DNA strands.
These results support the hypothesis that an intra-S check-
point operates in egg extracts to prevent further initiation
events in the presence of stalled replication forks. One attrac-
tive hypothesis is that, in response to aphidicolin, ATR and
Claspin are activated, leading to bifurcating signaling events.
One pathway leads to activation of Chk1 and inhibition of
Cdc2. The other pathway would lead to the accumulation of
Drf1-Cdc7 kinase on chromatin. Abrogation of this pathway by
caffeine would then allow Drf1-Cdc7 to participate in the load-
ing of Cdc45 onto chromatin. This process could involve either
new origin firing at unreplicated sites or resumption of repli-
cation within regions in which origins have already fired. Mon-
tagnoli et al. (42) have proposed that the human Drf1 might be
a specific activator of Cdc7 to fire late origins selectively. Al-
though late origins have not been characterized in the Xenopus
egg extract system, our results nonetheless are consistent with
the possibility that Drf1 plays some role in origin utilization
during a DNA replication block.
Another related possibility is that Drf1-Cdc7 acts to ensure
proper resumption of DNA replication upon recovery from the
arrest. In fission yeast, dfp1 and hsk1 mutants exhibit severe
defects in recovery from hydroxyurea arrest, consistent with a
role in re-starting stalled replication forks (15, 56). In Xenopus,
ATR and Claspin may participate in the recovery process by
recruiting or stabilizing Drf1 and Cdc7 on chromatin. Chroma-
tin-bound Cdc7 has been shown to be capable of supporting
DNA replication (9). Thus, when the block to replication is
removed, the kinase is poised to load significant amounts of
Cdc45 either at origins or at stalled forks to quickly re-initiate
and complete DNA synthesis. In both egg extracts and XTC
cells, abrogation of this checkpoint could lead to premature
re-starting of replication forks and DNA unwinding even in the
presence of aphidicolin.
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